Average Co-Inventor Count = 7.36
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sloan-kettering Institute for Cancer Research (16 from 512 patents)
2. Merck + Co., Inc. (5 from 4,770 patents)
3. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
23 patents:
1. 8513234 - HIV integrase inhibitors
2. 8481575 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof
3. RE41990 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof
4. 7807684 - HIV reverse transcriptase inhibitors
5. 7750164 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof
6. 7393873 - Arylsulfonamide derivatives
7. 7332499 - Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides
8. 7091380 - N-biphenylmethyl aminocycloalkanecarboxamide derivatives
9. 6972335 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof
10. 6965034 - Synthesis of epothilones, intermediates thereto and analogues thereof
11. 6919343 - N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
12. 6908921 - Quinoxalinone derivatives as bradykinin B1 antagonists
13. 6849651 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof
14. 6828340 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof
15. 6723854 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof